Cyclo Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cyclo Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Cyclo Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 91.7 %, a 26.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 91.7 -32.9 -26.4% Jun 30, 2024
Q1 2024 104 -114 -52.3% Mar 31, 2024
Q4 2023 103 -252 -71.1% Dec 31, 2023
Q3 2023 88 -387 -81.5% Sep 30, 2023
Q2 2023 125 -350 -73.8% Jun 30, 2023
Q1 2023 219 -240 -52.3% Mar 31, 2023
Q4 2022 355 -92.4 -20.7% Dec 31, 2022
Q3 2022 475 +61.5 +14.9% Sep 30, 2022
Q2 2022 475 +140 +41.7% Jun 30, 2022
Q1 2022 459 +221 +92.5% Mar 31, 2022
Q4 2021 447 +310 +227% Dec 31, 2021
Q3 2021 413 +336 +436% Sep 30, 2021
Q2 2021 335 +232 +227% Jun 30, 2021
Q1 2021 238 +80.6 +51.1% Mar 31, 2021
Q4 2020 137 -36.5 -21.1% Dec 31, 2020
Q3 2020 77.1 -106 -57.8% Sep 30, 2020
Q2 2020 103 Jun 30, 2020
Q1 2020 158 Mar 31, 2020
Q4 2019 173 Dec 31, 2019
Q3 2019 183 Sep 30, 2019
Q4 2016 252 -30.5 -10.8% Dec 31, 2016
Q3 2016 233 -69.8 -23.1% Sep 30, 2016
Q2 2016 260 -118 -31.3% Jun 30, 2016
Q1 2016 259 -228 -46.8% Mar 31, 2016
Q4 2015 283 -333 -54.1% Dec 31, 2015
Q3 2015 303 -553 -64.6% Sep 30, 2015
Q2 2015 378 -225 -37.2% Jun 30, 2015
Q1 2015 487 +88 +22.1% Mar 31, 2015
Q4 2014 616 +359 +140% Dec 31, 2014
Q3 2014 856 +653 +322% Sep 30, 2014
Q2 2014 603 +474 +367% Jun 30, 2014
Q1 2014 399 +321 +409% Mar 31, 2014
Q4 2013 257 +193 +303% Dec 31, 2013
Q3 2013 203 +148 +269% Sep 30, 2013
Q2 2013 129 +69.8 +117% Jun 30, 2013
Q1 2013 78.4 -0.96 -1.21% Mar 31, 2013
Q4 2012 63.7 Dec 31, 2012
Q3 2012 55 Sep 30, 2012
Q2 2012 59.5 Jun 30, 2012
Q1 2012 79.4 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.